Page last updated: 2024-10-23

bisoprolol and Metabolic Syndrome

bisoprolol has been researched along with Metabolic Syndrome in 1 studies

Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.

Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.

Research Excerpts

ExcerptRelevanceReference
"Thirty patients (18 women and 12 men) with metabolic syndrome and mild arterial hypertension took bisoprolol alone in a dose 5-10 mg/day, and fifteen patients received combined therapy (bisoprolol and actovegin) for 12 weeks."3.73[Primary prophylaxis of cerebrovascular complications in patients with metabolic syndrome]. ( Chazova, IE; Gornostaev, VV; Mychka, VB; Sergienko, VB, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mychka, VB1
Chazova, IE1
Gornostaev, VV1
Sergienko, VB1

Other Studies

1 other study available for bisoprolol and Metabolic Syndrome

ArticleYear
[Primary prophylaxis of cerebrovascular complications in patients with metabolic syndrome].
    Terapevticheskii arkhiv, 2005, Volume: 77, Issue:10

    Topics: Adult; Antihypertensive Agents; Bisoprolol; Brain; Carbohydrate Metabolism; Cerebrovascular Circulat

2005